Skip to main content
Activebkms-ef-91006a35-05ca-4d31-b8ed-56daf81a4094

Discount Agreements for Bevacizumab and Rituximab

GWQ ServicePlus AG is entering into non-exclusive discount agreements for Bevacizumab and Rituximab to optimize the drug supply for statutory health insurance funds starting July 1, 2026.

CONTRACTING AUTHORITY

Name

GWQ ServicePlus AG

City

Düsseldorf

Country

DE

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000, Pharmaceutical products.

LOTS (2)

LOT-0001Supplies

Rabattvereinbarung für Bevacizumab

LOT-0002Supplies

Rabattvereinbarung für Rituximab

ADDITIONAL DETAILS

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

713 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now